Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested CapitalReturn on AssetsReturn on EquityReturn on Sales

Trinity Biotech (TRIB) Invested Capital (2016 - 2025)

Historic Invested Capital for Trinity Biotech (TRIB) over the last 13 years, with Q2 2025 value amounting to -$48.4 million.

  • Trinity Biotech's Invested Capital fell 7321.51% to -$48.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$48.4 million, marking a year-over-year decrease of 7321.51%. This contributed to the annual value of -$33.5 million for FY2024, which is 4312.0% down from last year.
  • As of Q2 2025, Trinity Biotech's Invested Capital stood at -$48.4 million, which was down 7321.51% from -$33.5 million recorded in Q4 2024.
  • Trinity Biotech's 5-year Invested Capital high stood at $17.8 million for Q2 2022, and its period low was -$48.4 million during Q2 2025.
  • For the 5-year period, Trinity Biotech's Invested Capital averaged around -$11.9 million, with its median value being -$6.6 million (2023).
  • Data for Trinity Biotech's Invested Capital shows a peak YoY increase of 369294.35% (in 2022) and a maximum YoY decrease of 484881.89% (in 2022) over the last 5 years.
  • Trinity Biotech's Invested Capital (Quarter) stood at -$319000.0 in 2021, then crashed by 582.13% to -$2.2 million in 2022, then tumbled by 976.42% to -$23.4 million in 2023, then plummeted by 43.12% to -$33.5 million in 2024, then tumbled by 44.45% to -$48.4 million in 2025.
  • Its last three reported values are -$48.4 million in Q2 2025, -$33.5 million for Q4 2024, and -$26.3 million during Q3 2024.